WANBURY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161 INR | +0.21% |
|
-1.49% | +27.73% |
| 06-18 | US FDA Clears Wanbury's Patalganga, India Site; Shares Climb 4% | MT |
| 04-01 | Wanbury Limited Announces Retirement of Narinder Kumar Puri as Independent Director | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 43.29B | ||||||
| 22.38B | ||||||
| 15.51B | ||||||
| 14.52B | ||||||
| 12.93B |
